Respiratory Complication: Clinical Trials

4 trials for Respiratory Complication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Recruiting 1

Follow Respiratory Complication: new trials by email Literature Review of Respiratory Complication trials Research Report on Respiratory Complication

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle
Fentanyl Injection - Respiratory Function Loss, Respiratory Complication
Phase 4RecruitingMayo Clinic692023-06-192026-09-17
Perioperative Respiratory Adverse events_sugammadex
Sugammadex injection, Neostigmine - Respiratory Complication
Phase 4CompletedSeoul National University Hospital1742022-06-272024-09-20
Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
Sugammadex 100 MG/ML [Bridion] - Respiratory Complication, Obstructive Sleep Apnea
Phase 4CompletedUniversity of California, Los Angeles122482022-02-182025-07-29
Comparison of Different Approaches for Supraclavicular Block and Their Effects on Diaphragm Muscle Function
Bupivacaine HCl 0.5% Injectable Solution, Prilocaine HCl % 2 injectable solution, adrenaline amp 0.5mg - Phrenic Nerve Paralysis, Diaphragm Sellae Meningioma
Phase 4CompletedBozyaka Training and Research Hospital902021-02-162023-06-13

Narrower conditions

Sleep Apnea, Obstructive (1)

Broader conditions

Apnea (1)  ·  Dyssomnias (1)  ·  Nervous System Diseases (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)

Interventions

Sugammadex (2)  ·  Bupivacaine (1)  ·  Fentanyl (1)  ·  High-Energy Shock Waves (1)  ·  Neostigmine (1)

Sponsors

Bozyaka Training and Research Hospital (1)  ·  Mayo Clinic (1)  ·  Seoul National University Hospital (1)  ·  University of California, Los Angeles (1)

Countries

United States (2)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Carlos Mantilla, MD, PhD (1)

Results publications

PMID 42414111

NIH funding

R21DA055848 (1)